Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo

Pfizer Inc. has agreed to buy Metsera Inc. in a $10 billion deal, following a tumultuous bidding war with Novo Nordisk A/S ...

Metsera accepts Pfizer's $10 billion acquisition bid in ongoing M&A battle

Pfizer appeared to have locked up the acquisition in September before Novo jumped in last week with an unsolicited offer, ...
NewsBytes

Pfizer to acquire Metsera for $10B, beating out Novo Nordisk

Metsera, an obesity drug developer, has accepted a $10 billion acquisition offer from pharmaceutical giant Pfizer, potentially concluding a bidding war with Novo Nordisk.
The Edge Singapore

Pfizer sweetens offer for Metsera in bidding war against Novo

Metsera said that Pfizer will pay up to US$86.25 a share, including US$65.60 a share in cash initially, plus potential additional payments of up to US$20.65 a share for hitting certain milestones.